These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 503252)

  • 1. Inhibition by cholinergic agonists of the prolactin release induced by morphine.
    Muraki T; Tokunaga Y; Nakadate T; Kato R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):249-54. PubMed ID: 503252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for adrenergic mediation of cholinergic inhibition of prolactin release.
    Grandison L; Meites J
    Endocrinology; 1976 Sep; 99(3):775-9. PubMed ID: 954668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of morphine with the cholinergic system on prolactin release.
    Fanjul LF; Ruiz de Galarreta CM; Meites J
    Proc Soc Exp Biol Med; 1981 Apr; 166(4):542-5. PubMed ID: 7220547
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.
    Newman LM
    J Comp Physiol Psychol; 1972 Jun; 79(3):394-413. PubMed ID: 5054476
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic modification of naloxone-induced jumping in morphine dependent mice.
    Brase DA; Tseng LF; Loh HH; Way EL
    Eur J Pharmacol; 1974 Apr; 26(1):1-8. PubMed ID: 4857603
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a cholinergic influence on catecholaminergic pathways terminating in the anterior and medial basal hypothalamus.
    Morgan WW; Pfeil KA
    Brain Res; 1979 Sep; 173(1):47-56. PubMed ID: 487084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine inhibits dopaminergic and cholinergic induced ejaculation in rats.
    Zarrindast MR; Mamanpush SM; Rashidy-Pour A
    Gen Pharmacol; 1994 Jul; 25(4):803-8. PubMed ID: 7958745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone blocks nicotine-induced prolactin release.
    Flores CM; Hulihan-Giblin BA; Kellar KJ
    Neuropharmacology; 1989 Nov; 28(11):1287-90. PubMed ID: 2594167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC; Pinsky C
    J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for cholinergic control of gonadotropin and prolactin secretion.
    Libertun C; McCann SM
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):498-504. PubMed ID: 4612554
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of prolactin secretion by cholinergic drug.
    Grandison L; Gelato M; Meites J
    Proc Soc Exp Biol Med; 1974 Apr; 145(4):1236-9. PubMed ID: 4827734
    [No Abstract]   [Full Text] [Related]  

  • 17. Restraint stress decreases afternoon plasma prolactin levels in female rats. Influence of neural antagonists and agonists on restraint-induced changes in plasma prolactin and corticosterone.
    Gala RR; Haisenleder DJ
    Neuroendocrinology; 1986; 43(2):115-23. PubMed ID: 3724981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bombesin on basal, alpha-methyl-p-tyrosine, haloperidol, morphine, bremazocine and stress-induced prolactin secretion.
    Buydens P; Govaerts J; Velkeniers B; Finné E; Vanhaelst L
    Life Sci; 1988; 43(21):1755-60. PubMed ID: 2904106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation.
    Yamamoto KI; Domino EF
    Int J Neuropharmacol; 1967 Sep; 6(5):357-73. PubMed ID: 6069723
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans.
    Risch SC; Janowsky DS; Siever LJ; Judd LJ; Rausch JL; Huey LY; Beckman KA; Cohen RM; Murphy DL
    Peptides; 1982; 3(3):319-22. PubMed ID: 6289276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.